Correlation Between ARK Genomic and IShares Dividend

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ARK Genomic and IShares Dividend at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ARK Genomic and IShares Dividend into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ARK Genomic Revolution and iShares Dividend and, you can compare the effects of market volatilities on ARK Genomic and IShares Dividend and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ARK Genomic with a short position of IShares Dividend. Check out your portfolio center. Please also check ongoing floating volatility patterns of ARK Genomic and IShares Dividend.

Diversification Opportunities for ARK Genomic and IShares Dividend

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between ARK and IShares is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding ARK Genomic Revolution and iShares Dividend and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Dividend and ARK Genomic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ARK Genomic Revolution are associated (or correlated) with IShares Dividend. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Dividend has no effect on the direction of ARK Genomic i.e., ARK Genomic and IShares Dividend go up and down completely randomly.

Pair Corralation between ARK Genomic and IShares Dividend

Given the investment horizon of 90 days ARK Genomic Revolution is expected to generate 4.35 times more return on investment than IShares Dividend. However, ARK Genomic is 4.35 times more volatile than iShares Dividend and. It trades about 0.2 of its potential returns per unit of risk. iShares Dividend and is currently generating about 0.4 per unit of risk. If you would invest  2,446  in ARK Genomic Revolution on November 2, 2024 and sell it today you would earn a total of  282.00  from holding ARK Genomic Revolution or generate 11.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

ARK Genomic Revolution  vs.  iShares Dividend and

 Performance 
       Timeline  
ARK Genomic Revolution 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in ARK Genomic Revolution are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak forward-looking signals, ARK Genomic reported solid returns over the last few months and may actually be approaching a breakup point.
iShares Dividend 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Dividend and are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, IShares Dividend is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

ARK Genomic and IShares Dividend Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ARK Genomic and IShares Dividend

The main advantage of trading using opposite ARK Genomic and IShares Dividend positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ARK Genomic position performs unexpectedly, IShares Dividend can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Dividend will offset losses from the drop in IShares Dividend's long position.
The idea behind ARK Genomic Revolution and iShares Dividend and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities